Advertisement

Oxford COVID-19 vaccine 'highly effective' in trials, company says

AstraZeneca says late-stage trials showed that its COVID-19 vaccine candidate with Oxford University was up to 90 per cent effective in preventing disease. AstraZeneca is the third major drug company to report late-stage results for its potential vaccine.